Posts

stem cells and hair loss

Global Stem Cell Alopecia Treatment Market

Global Stem Cell Alopecia Treatment Market Size, Status and Forecast 2019-2025

The stem cells, which are stimulated by the drug, replenish or restore cells associated with the induction of hair growth.
In 2018, the global Stem Cell Alopecia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Stem Cell Alopecia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Alopecia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

APEX Biologix
Belgravia Center
Kerastem
Riken Research Institute
RepliCel
Sanford Burnham Prebys Medical Discovery Institute

Market segment by Type, the product can be split into

Alopecia Areata
Alopecia Totalis
Alopecia Universalis

Market segment by Application, split into

Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Stem Cell Alopecia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell Alopecia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell Alopecia Treatment  are as follows:

History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Stem Cell Alopecia Treatment  Market Size, Status and Forecast 2019-2025

Source

Previous Posts

stem cells and hair loss

Global Stem Cell Alopecia Treatment Market

Global Stem Cell Alopecia Treatment Market Size, Status and Forecast 2019-2025

The stem cells, which are stimulated by the drug, replenish or restore cells associated with the induction of hair growth.
In 2018, the global Stem Cell Alopecia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Stem Cell Alopecia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Alopecia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

APEX Biologix
Belgravia Center
Kerastem
Riken Research Institute
RepliCel
Sanford Burnham Prebys Medical Discovery Institute

Market segment by Type, the product can be split into

Alopecia Areata
Alopecia Totalis
Alopecia Universalis

Market segment by Application, split into

Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Stem Cell Alopecia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell Alopecia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell Alopecia Treatment  are as follows:

History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Stem Cell Alopecia Treatment  Market Size, Status and Forecast 2019-2025

Source

Previous Posts

Kerastem and Stem Cell Hair Growth Technology

Kerastem and Stem Cell Hair Growth Technology

Kerastem and Myungmoon Bio Partner to Commercialize Stem Cell Hair Growth Technology

Kerastem, the global leader in the development and commercialization of regenerative medicine-based approaches to hair growth and Myungmoon Bio Co, LTD a healthcare company focused on bringing innovative regenerative therapies to market, announce their partnership to commercialize Kerastem’s novel hair growth therapy in South Korea.

“The partnership with Myungmoon represents a significant milestone for Kerastem, providing access to one of the largest and most sophisticated aesthetic markets in the world,” said Bradford A. Conlan, CEO of Kerastem.

Kerastem recently reported 12-month top-line data from its clinical trial (STYLE), a 70 patient, phase II, US multi-center, randomized, single-blinded, and a controlled study investigating Kerastem’s therapy in patients with early hair loss.

Results from STYLE demonstrated a statistically significant increase in the number of mature hairs in men treated with Kerastem when compared to placebo control. Early hair loss represents a significant unmet medical need and the Kerastem therapy is a one-time treatment that utilizes adipose (fat) derived regenerative cells delivered to the affected area of the scalp.

Added Mr. Conlan, “the company is positioned for success considering the excellent results observed from our US phase II clinical trial where a specific dose was identified that grows hair.”

ANDROGENETIC ALOPECIA MARKET SIZE

Hair loss affects more than 25% of all men and women in South Korea alone. The global hair loss treatment market generates more than $7 Billion in revenue annually and currently has limited options for men and women with early stage hair loss.

BIOTECH SHOWCASE 2019

Kerastem will be providing a general corporate update as a presenting company at the upcoming Biotech Showcase 2019 on January 9th at 1:30 pm pacific time. The company is actively seeking additional licensing partnerships. Kerastem is a wholly owned subsidiary of Bimini Technologies.

The Bimini portfolio includes Puregraft (http://www.puregraft.com, the world’s leading fat transfer solution. In 15 minutes or less, Puregraft products provide surgeons with purified fat for reinjection and are used in hospitals and clinics around the world. The existing Puregraft customer base are ideal prospects for the new Kerastem technology.

CONTACT

Learn more about Kerastem at http://www.kerastem.com or click on the following link: https://youtu.be/oaaZnCq-ONA

Kerastem and Myungmoon Bio Partner to Commercialize Stem Cell Hair Growth Technology

Source

 

Previous Posts